Saturday, March 14, 2009
MIT Researchers Develop a Novel Drug-Delivery Gel
Shuguang Zhang, associate director of MIT's Center for Biomedical Engineering and his team have shown that a special gel may be used to deliver medications such as insulin, hormones, growth factors, or monoclonal antibodies like trastuzumab (Herceptin). The gel is being called a "nanofiber hydrogel scaffold." Wow, try explaining that to patients. This research was funded in part by the National Institutes of Health (NIH) and the High Q Foundation. The High Q Foundation, Inc. is a private philanthropic foundation that was established in 2002 with the mission of bringing together academia, industry, governmental agencies, and other funding organizations in the search for Huntington disease (HD) treatments.